Inspira Prepares Production for Respiratory Virus Outbreak
Ticker: IINNW · Form: 6-K · Filed: Jan 10, 2025 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: medical-devices, public-health, production-update
TL;DR
Inspira gearing up production due to China virus outbreak - could be a big demand driver.
AI Summary
On January 10, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced preparations for production in response to a respiratory virus outbreak in China. The company is leveraging its technology to address potential demand for respiratory support devices.
Why It Matters
This filing indicates Inspira Technologies is proactively responding to a public health crisis, potentially leading to increased demand for their medical devices.
Risk Assessment
Risk Level: medium — The company's response to a virus outbreak introduces uncertainty regarding demand, production capacity, and regulatory approvals.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- January 10, 2025 (date) — Date of press release
- China (location) — Location of respiratory virus spread
FAQ
What specific respiratory virus is Inspira Technologies responding to?
The filing mentions a 'respiratory virus' but does not specify the exact type of virus.
What is Inspira Technologies' core technology that will be used?
The filing refers to the company's technology for respiratory support devices, but does not detail the specific technology.
When was the press release issued?
The press release was issued on January 10, 2025.
What is the company's primary business address?
The company's principal executive office is located at 2 Ha-Tidhar St., Ra'anana 4366504, Israel.
Is Inspira Technologies filing a Form 20-F or 40-F for its annual report?
Inspira Technologies indicates it files annual reports under cover of Form 20-F.
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2025-01-10 06:34:33
Filing Documents
- ea0227344-6k_inspira.htm (6-K) — 13KB
- ea022734401ex99-1_inspira.htm (EX-99.1) — 9KB
- 0001213900-25-002298.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: January 10, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2